Additionally, study showed that HCC patients with high serum TNFRSF11B, also known as osteoprotegerin (OPG), level had poorer survival rates compared with HCC patients with low OPG level [44]. The gene discussed is TNFRSF11B; the disease is hepatocellular carcinoma.